Blessing Atim Aderibigbe
Overview
Explore the profile of Blessing Atim Aderibigbe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
930
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peter S, Khwaza V, Alven S, Naki T, Aderibigbe B
Pharmaceutics
. 2025 Feb;
17(2).
PMID: 40006557
There are different types of cancer treatments, including surgery, radiotherapy, and chemotherapy. However, the complexity of cancer has resulted in treatment challenges to medicinal scientists and a socio-economic burden to...
2.
Mbese Z, Choene M, Morifi E, Nwamadi M, Adeyemi S, Oyebamiji A, et al.
Chem Biodivers
. 2024 Sep;
22(1):e202400373.
PMID: 39278836
Designing hybrid-based drugs is one promising strategy for developing effective anticancer drugs that explore combination therapy to enhance treatment efficacy, overcome the development of drug resistance, and lower treatment duration....
3.
Chitosan-Based Scaffolds Incorporated with Silver Nanoparticles for the Treatment of Infected Wounds
Alven S, Aderibigbe B
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543221
Bacterial infections are major problems in wound care due to their impact on the retarded process of wound healing, leading to chronic wounds. Most of the presently utilized wound dressing...
4.
Khwaza V, Oselusi S, Morifi E, Nwamadi M, Hlope K, Ndinteh D, et al.
Recent Adv Antiinfect Drug Discov
. 2024 Feb;
19(3):232-253.
PMID: 38317466
Background: There is a critical need for the discovery of novel and effective antibacterial or anticancer molecules. Objectives: Amine-linked ursolic acid-based hybrid compounds were prepared in good yields in the...
5.
Aderibigbe B
Ther Deliv
. 2024 Jan;
PMID: 38174574
The treatment of fungal infections is challenging with high death rates reported among immunocompromised patients. The currently available antifungals suffer from poor bioavailability and solubility, pharmacokinetics, and drug resistance, with...
6.
Peter S, Aderibigbe B
Molecules
. 2023 Oct;
28(19).
PMID: 37836732
Increasing cases of cancer have been a primary concern in recent decades. Developing new chemotherapeutics is challenging and has been faced with limitations, such as multidrug resistance, poor specificity, selectivity,...
7.
Alven S, Ubanako P, Adeyemi S, Ndinteh D, Choonara Y, Aderibigbe B
Ther Deliv
. 2023 May;
14(2):139-156.
PMID: 37125434
Essential oils are promising antibacterial and wound-healing agents that should be explored for the design of wound dressings. Topical gels prepared from a combination of carboxymethyl cellulose and poloxamer were...
8.
Naki T, Matshe W, Balogun M, Sinha Ray S, Egieyeh S, Aderibigbe B
J Microencapsul
. 2023 Jan;
40(1):15-28.
PMID: 36622880
Aim: To prepare polymer-drug conjugates containing a combination of memantine, tacrine, and )--(3-aminopropyl)cinnamide, promising therapeutics for the treatment of neurodegenerative disorders. Methods: The conjugates were characterised by HNMR, particle size...
9.
Feketshane Z, Alven S, Aderibigbe B
Polymers (Basel)
. 2022 Oct;
14(19).
PMID: 36236046
Several factors, such as bacterial infections, underlying conditions, malnutrition, obesity, ageing, and smoking are the most common issues that cause a delayed process of wound healing. Developing wound dressings that...
10.
Buyana B, Naki T, Alven S, Aderibigbe B
Int J Mol Sci
. 2022 Oct;
23(19).
PMID: 36232561
Colorectal cancer is a common cancer in both men and women. Numerous studies on the therapeutic effectiveness of nanoparticles against colorectal cancer have been reported. Platinum treatments as well as...